These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 23873327)

  • 101. Safety and efficacy of ranolazine in hypertrophic cardiomyopathy: Real-world experience in a National Referral Center.
    Argirò A; Zampieri M; Dei LL; Ferrantini C; Marchi A; Tomberli A; Baldini K; Cappelli F; Favilli S; Passantino S; Zocchi C; Tassetti L; Gabriele M; Maurizi N; Marchionni N; Coppini R; Olivotto I
    Int J Cardiol; 2023 Jan; 370():271-278. PubMed ID: 36228766
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Ranolazine as add-on therapy for patients with severe chronic angina.
    Hooper JS; Busti AJ
    JAMA; 2004 Apr; 291(16):1959; author reply 1959-60. PubMed ID: 15113810
    [No Abstract]   [Full Text] [Related]  

  • 103. Long-term benefits and limitations of combined antianginal drug therapy in elderly patients with symptomatic chronic coronary artery disease.
    Bonetti PO; Kaiser C; Zellweger MJ; Grize L; Erne P; Schoenenberger RA; Pfisterer ME;
    J Cardiovasc Pharmacol Ther; 2005 Mar; 10(1):29-37. PubMed ID: 15821836
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Role of Ranolazine in cardiovascular disease and diabetes: Exploring beyond angina.
    Banerjee K; Ghosh RK; Kamatam S; Banerjee A; Gupta A
    Int J Cardiol; 2017 Jan; 227():556-564. PubMed ID: 27838121
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Chronic stable angina pectoris.
    Jawad E; Arora R
    Dis Mon; 2008 Sep; 54(9):671-89. PubMed ID: 18725007
    [No Abstract]   [Full Text] [Related]  

  • 106. Metabolic management of ischaemic heart disease.
    Chierchia SL; Fragasso G
    Eur Heart J; 1993 Nov; 14 Suppl G():2-5. PubMed ID: 7904560
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Ranolazine, a novel agent for chronic stable angina.
    Gaffney SM
    Pharmacotherapy; 2006 Jan; 26(1):135-42. PubMed ID: 16506355
    [TBL] [Abstract][Full Text] [Related]  

  • 108. The evolving role of medical therapy for chronic stable angina.
    Eid F; Boden WE
    Curr Cardiol Rep; 2008 Jul; 10(4):263-71. PubMed ID: 18611360
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Relationship Between Optimism and Outcomes in Patients With Chronic Angina Pectoris.
    Fanaroff AC; Prather K; Brucker A; Wojdyla D; Davidson-Ray L; Mark DB; Williams RB; Barefoot J; Weisz G; Ben-Yehuda O; Stone GW; Ohman EM; Alexander KP
    Am J Cardiol; 2019 May; 123(9):1399-1405. PubMed ID: 30771861
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Efficacy and safety of ranolazine in patients with chronic stable angina.
    Kloner RA; Hines ME; Geunes-Boyer S
    Postgrad Med; 2013 Nov; 125(6):43-52. PubMed ID: 24200760
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Diabetes and coronary disease: a need for new therapies for an expanding disease burden.
    Lew WY; DeMaria AN
    J Am Coll Cardiol; 2013 May; 61(20):2046-7. PubMed ID: 23500323
    [No Abstract]   [Full Text] [Related]  

  • 112. [Conservative therapy of patients with stable coronary heart disease].
    Custodis F; Laufs U
    Herz; 2012 Feb; 37(1):85-96. PubMed ID: 22331062
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Expanding the understanding of the treatment of chronic angina: a 21st century approach-part II.
    Conti CR
    Clin Cardiol; 2008 Jul; 31(7):295-6. PubMed ID: 18636470
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Treatment of Angina Pectoris Associated with Coronary Microvascular Dysfunction.
    Ong P; Athanasiadis A; Sechtem U
    Cardiovasc Drugs Ther; 2016 Aug; 30(4):351-356. PubMed ID: 27358172
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Is randomization to placebo safe? Risk in placebo-controlled angina trials: angina risk meta-analysis.
    Glasser SP; Willard J; Defelice A; Lawrence J; Hung J; Obot E; Girton J; Targum S; Throckmorton D; Mangano D; Lipicky RJ
    Cardiology; 2011; 120(3):174-81. PubMed ID: 22261892
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Pharmacological approaches of refractory angina.
    Giannopoulos AA; Giannoglou GD; Chatzizisis YS
    Pharmacol Ther; 2016 Jul; 163():118-31. PubMed ID: 27013345
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Ranolazine for the treatment of chronic stable angina: a cost-effectiveness analysis from the UK perspective.
    Coleman CI; Freemantle N; Kohn CG
    BMJ Open; 2015 Nov; 5(11):e008861. PubMed ID: 26546142
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Ranolazine: a review of its use as add-on therapy in patients with chronic stable angina pectoris.
    Keating GM
    Drugs; 2013 Jan; 73(1):55-73. PubMed ID: 23329466
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Expanding the understanding of the treatment of chronic angina: a 21st century approach--part 1.
    Conti CR
    Clin Cardiol; 2008 Jun; 31(6):239-40. PubMed ID: 18543302
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Ranolazine After Incomplete Percutaneous Coronary Revascularization in Patients With Versus Without Diabetes Mellitus: RIVER-PCI Trial.
    Fanaroff AC; James SK; Weisz G; Prather K; Anstrom KJ; Mark DB; Ben-Yehuda O; Alexander KP; Stone GW; Ohman EM
    J Am Coll Cardiol; 2017 May; 69(18):2304-2313. PubMed ID: 28473136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.